ENGNInvestor Conferences•businesswire•August 27, 2025 at 12:00 PM

enGene to Participate in Upcoming Investor Conferences

Sentiment:Negative (35)

Summary

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral gene therapy company, today announced that management will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference Date: Wednesday, September 3, 2025 Time: 8:45 a.m. ET H.C. Wainwright 27th Annual Global Investment Conference Date: Monday, September 8, 2025 Time: 1:30 p.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference Date:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 27, 2025 by businesswire